Mar 29, 2023 / 12:00PM GMT
Operator
Hello, and welcome to the Pieris Pharmaceuticals, Inc. Year-End 2022 Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Tom Bures. Please go ahead, sir.
Thomas Bures - Pieris Pharmaceuticals, Inc. - Senior VP & CFO
Thanks, Kevin. Good morning, everyone, and thank you for joining us for our year-end 2022 conference call and corporate update. On the call today we have Steve Yoder, our President and CEO, who will provide a corporate overview and outlook on our pipeline; Hitto Kaufmann, our Chief Scientific Officer; Shane Olwill, our Chief Development Officer; and Mary Fitzgerald, Vice President, Project Leader for elarekibep, who will be available for Q&A. You can access the press release issued this morning on the Investor Relations page of our website at www.pieris.com.
Before we begin, I'd like to caution that comments made during this conference call may contain forward
Q4 2022 Pieris Pharmaceuticals Inc Earnings Call Transcript
Mar 29, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers